Docetaxel for Injection (Albumin Bound)

docetaxel (albumin-bound formulation) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Docetaxel for Injection (Albumin Bound), covering 2022-10-13 to 2024-11-14. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer [Phase 3]